Brief: Central Garden & Pet Q3 Adjusted EPS USD 1.56 Vs. IBES Estimate USD 1.43

Central Garden & Pet

06/08/2025 21:05

Overview

Central Garden & Pet Q3 sales fall 4%, missing analyst expectations, per LSEG data

Adjusted EPS for Q3 rises 18%, beating analyst estimates, per LSEG data

Co reaffirms fiscal 2025 non-GAAP EPS outlook of about $2.60

Outlook

Central reaffirms fiscal 2025 non-GAAP EPS of approximately $2.60

Company anticipates fiscal 2025 capital expenditures of $50 to $60 mln

Central sees challenges from macroeconomic and geopolitical uncertainty

Company excludes tariff changes impact from fiscal 2025 outlook

Result Drivers

COST AND SIMPLICITY PROGRAM - Co attributes margin expansion and earnings growth to productivity efforts from its Cost and Simplicity program

PET SEGMENT CHALLENGES - Softer demand in durable pet products and assortment rationalization led to a 3% decline in Pet segment sales

GARDEN SEGMENT CHALLENGES - Loss of product lines and a late spring impacted Garden segment sales, but productivity efforts increased operating income

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Sales
Miss
$961 mln
$991.70 mln (5 Analysts)
Q3 Adjusted EPS
Beat
$1.56
$1.43 (6 Analysts)
Q3 EPS
$1.52
Q3 Net Income
$95 mln
Q3 Operating Income
Beat
$135 mln
$127.90 mln (4 Analysts)
Q3 Gross Profit
$332 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the food processing peer group is "buy"

Wall Street's median 12-month price target for Central Garden & Pet Co is $45.00, about 12% above its August 5 closing price of $39.62

The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release: ID:nBw3Bld2ka

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)